Jiang L - Search Results

1

R-spondin family members as novel biomarkers and prognostic factors in lung cancer.

Wu L, Zhang W, Qian J, Wu J, Jiang L, Ling C. Wu L, et al. Among authors: jiang l. Oncol Lett. 2019 Oct;18(4):4008-4015. doi: 10.3892/ol.2019.10778. Epub 2019 Aug 22. Oncol Lett. 2019. PMID: 31579414 Free PMC article.

2

Anti-inflammatory drug, leflunomide and its metabolite teriflunomide inhibit NSCLC proliferation in vivo and in vitro.

Jiang L, Zhang W, Li W, Ling C, Jiang M. Jiang L, et al. Among authors: jiang m. Toxicol Lett. 2018 Jan 5;282:154-165. doi: 10.1016/j.toxlet.2017.10.013. Epub 2017 Oct 16. Toxicol Lett. 2018. PMID: 29050931

3

Nimotuzumab, an EGFR‑targeted antibody, promotes radiosensitivity of recurrent esophageal squamous cell carcinoma.

Yu Y, Guan H, Jiang L, Li X, Xing L, Sun X. Yu Y, et al. Among authors: jiang l. Int J Oncol. 2020 Apr;56(4):945-956. doi: 10.3892/ijo.2020.4981. Epub 2020 Feb 12. Int J Oncol. 2020. PMID: 32319582

4

Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study.

Zhou S, Ren F, Li C, Jiang L, Meng X, Huang Z. Zhou S, et al. Among authors: jiang l. J Neurooncol. 2022 Dec;160(3):631-642. doi: 10.1007/s11060-022-04182-6. Epub 2022 Nov 8. J Neurooncol. 2022. PMID: 36346496

5

Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma.

Xu Y, Shen D, Liu J, Xu X, Tu J, Qin L, Jiang L, Qian H, Guo F. Xu Y, et al. Among authors: jiang l. J Mol Histol. 2020 Dec;51(6):659-673. doi: 10.1007/s10735-020-09912-6. Epub 2020 Oct 9. J Mol Histol. 2020. PMID: 33034797

6

Is there role of adjuvant radiotherapy after complete resection of locally advanced nonsmall cell lung cancer?

Jiang L, Meng X. Jiang L, et al. Curr Opin Oncol. 2024 Jan 1;36(1):44-50. doi: 10.1097/CCO.0000000000001004. Epub 2023 Oct 20. Curr Opin Oncol. 2024. PMID: 37865829 Review.

7

Proton beam therapy for cancer in the era of precision medicine.

Hu M, Jiang L, Cui X, Zhang J, Yu J. Hu M, et al. Among authors: jiang l. J Hematol Oncol. 2018 Dec 12;11(1):136. doi: 10.1186/s13045-018-0683-4. J Hematol Oncol. 2018. PMID: 30541578 Free PMC article. Review.

8

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.

Zhang X, Yu J, Zhu H, Meng X, Li M, Jiang L, Ding X, Sun X. Zhang X, et al. Among authors: jiang l. Oncotarget. 2017 Mar 28;8(13):22251-22261. doi: 10.18632/oncotarget.14759. Oncotarget. 2017. PMID: 28118612 Free PMC article. Review.

9

Perspective on treatment for unresectable locally advanced non-small cell lung cancer with oncogene-driven mutation: a narrative review.

Jiang L, Meng X, Zhao X, Xing L, Yu J. Jiang L, et al. Transl Lung Cancer Res. 2020 Oct;9(5):2137-2144. doi: 10.21037/tlcr-20-722. Transl Lung Cancer Res. 2020. PMID: 33209632 Free PMC article. Review.

10

TGIF1 plays a carcinogenic role in esophageal squamous cell carcinoma through the Wnt/β‑catenin and Akt/mTOR signaling pathways.

Kong L, Yu Y, Guan H, Jiang L, Sun F, Li X, Huang W, Li B. Kong L, et al. Among authors: jiang l. Int J Mol Med. 2021 May;47(5):77. doi: 10.3892/ijmm.2021.4910. Epub 2021 Mar 11. Int J Mol Med. 2021. PMID: 33693954 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,670 results

Search Page

Filters